Naito H, Taoka R, Zhang X, Hossain A, et al. Enfortumab vedotin promotes PD-L1 expression in urothelial carcinoma via NF-kappaB and STAT3 pathways highlighting mechanisms of immune evasion and potential for combination therapy. BMC Immunol 2025;26:70.
PMID: 40999385